Grant: CIHR Fellowship
McGill University
$110,000.00
Building a clinical and genetic taxonomy of schizophrenia
EF 2023-24
Résumé
Schizophrenia (SCZ) is a leading cause of disability, bringing significant economic and personal costs. Despite progress in understanding its neurobiology, a gap in clinical translation persists due to marked heterogeneity seen in genetic, neuroimaging, and clinical trajectories. Hence, I will aim to establish a taxonomy of SCZ, viewing it as a group of conditions with diverse biological origins and clinical phenotypes. Through a systematized approach, we will organize SCZ into subgroups within genetics, intermediate phenotypes, and clinical presentations.
CLINICAL: diversity of clinical presentations existed historically, and we will seek to resolve these entities into a single system based on manually curated features and automated methods (semantic similarity between subtype descriptors). Correlations between subtypes will be used for hierarchical clustering, and a consensus taxonomy will be developed. GENETICS: We will leverage existing gene lists for clustering biological pathways in SCZ, using transcriptome (GTEx, Allen Human Brain Atlas), interactome (Human Interactome Database), gene-environment interactions (Comparative Toxicogenomics Database), phenotypes (Human Phenotype Ontology, DisGeNet), and gene-compound (ConnectivityMap). Within each omic, gene-gene correlations will produce weighted networks, then projected into multilayer networks. Multilayer correlation analysis and community structure detection will be used to create consensus gene networks that cut across biological scales.
This endeavor will foster a deeper understanding of SCZ neurobiology, and establish clinical terminology that is historically & neurobiologically grounded. Paving the way for personalized, subtype-specific treatments, our focus will shift from isolated brain regions or genes as treatment targets, to individual-specific biological pathways for treatment. Such a shift is positioned to advance precision medicine, aiming to improve individual recovery and long term outcomes.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
493288
Name
Park Min Tae M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Building a clinical and genetic taxonomy of schizophrenia
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$110,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Genetics; Neuroimaging; Schizophrenia
Abstract
Schizophrenia (SCZ) is a leading cause of disability, bringing significant economic and personal costs. Despite progress in understanding its neurobiology, a gap in clinical translation persists due to marked heterogeneity seen in genetic, neuroimaging, and clinical trajectories. Hence, I will aim to establish a taxonomy of SCZ, viewing it as a group of conditions with diverse biological origins and clinical phenotypes. Through a systematized approach, we will organize SCZ into subgroups within genetics, intermediate phenotypes, and clinical presentations.
CLINICAL: diversity of clinical presentations existed historically, and we will seek to resolve these entities into a single system based on manually curated features and automated methods (semantic similarity between subtype descriptors). Correlations between subtypes will be used for hierarchical clustering, and a consensus taxonomy will be developed. GENETICS: We will leverage existing gene lists for clustering biological pathways in SCZ, using transcriptome (GTEx, Allen Human Brain Atlas), interactome (Human Interactome Database), gene-environment interactions (Comparative Toxicogenomics Database), phenotypes (Human Phenotype Ontology, DisGeNet), and gene-compound (ConnectivityMap). Within each omic, gene-gene correlations will produce weighted networks, then projected into multilayer networks. Multilayer correlation analysis and community structure detection will be used to create consensus gene networks that cut across biological scales.
This endeavor will foster a deeper understanding of SCZ neurobiology, and establish clinical terminology that is historically & neurobiologically grounded. Paving the way for personalized, subtype-specific treatments, our focus will shift from isolated brain regions or genes as treatment targets, to individual-specific biological pathways for treatment. Such a shift is positioned to advance precision medicine, aiming to improve individual recovery and long term outcomes.
Competitiondate
202310
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Park, Min Tae M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $110,000~ $0~